GeneDx Holdings Corp. / Fundamentals

    Income statement

    Net revenue
    €312.16M
    Cost of goods sold
    €102.45M
    Gross profit
    €209.71M
    SG&A expenses
    €159.83M
    R&D expenses
    €43.86M
    EBITDA
    €9.79M
    D&A
    €6.98M
    EBIT
    €4.68M
    Interest expenses
    -€578.96K
    EBT
    €1.34M
    Tax expenses
    €556.56K
    Net income
    €1.21M

    Cash flow statement

    Net deferred tax
    €497.98K
    Non-cash items
    -€4.06M
    Changes in working capital
    -€3.61M
    Operating cash flow
    €20.79M
    Capex
    €15.79M
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€54.66M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €40.06M
    Debt repayment
    €852.93K
    Other financing cash flow
    €21.79M
    Net financing cash flow
    €62.70M
    Foreign exchange effects
    €0.00
    Net change in cash
    €102.16M
    Cash at end of period
    €64.71M
    Free cash flow
    €36.58M

    Balance sheet

    Cash and cash equivalents
    €63.86M
    Cash and short-term investments
    €115.93M
    Total receivables
    €41.38M
    Inventory
    €10.28M
    Other current assets
    €8.89M
    Total current assets
    €176.48M
    Property, plant & equipment
    €56.09M
    Goodwill
    €11.14M
    Intangible assets
    €152.23M
    Long-term investments
    €0.00
    Other non-current assets
    €3.72M
    Total non-current assets
    €223.16M
    Total assets
    €399.64M
    Accounts payable
    €0.00
    Short-term debt
    €2.66M
    Other current liabilities
    €58.86M
    Total current liabilities
    €61.52M
    Long-term debt
    €51.36M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €47.99M
    Total non-current liabilities
    €99.36M
    Total liabilities
    €160.88M
    Common stock
    €1.72K
    Retained earnings
    -€1.16B
    Other equity
    €699.58K
    Total equity
    €238.76M
    Total liabilities and shareholders' equity
    €399.64M

    Company information

    Market capitalization
    €1.91M
    Employees
    1K
    Enterprise Value
    €1.87B

    Company ratios

    Gross margin
    67.2% Much better than peer group: -1,300.1%
    EBITDA margin
    3.1% Much better than peer group: -10,802.1%
    EBIT margin
    1.5% Much better than peer group: -9,680.3%
    EBT margin
    0.4% Much better than peer group: -9,254.9%
    Net margin
    0.4% Much better than peer group: -9,793.6%
    ROE
    0.5% Much better than peer group: -29.4%
    ROA
    0.3% Much better than peer group: -1,060.2%
    Asset turnover
    78.1% Much better than peer group: 29.8%
    FCF margin
    1.6% Much better than peer group: -8,406.0%
    FCF yield
    262.0%
    Efficiency ratio
    96.9%
    Net sales per employee
    €312.16K
    Net income per employee
    €1.21K

    Notifications